The first national clinical audit of prostate cancer care

BJU International

Volumn 112, Issue 7, 2013, Pages 883-884

  Cathcart, Paul ^a   Nossiter, Julie ^b   Aggarwal, Ajay ^b   Rashbass, Jem ^c   Lyratzopoulos, Yoryos ^d   Payne, Heather ^a   Neal, David E ^d   Van Der Meulen, Jan ^b  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^c Eastern Cancer Registration and Information Centre   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER HORMONE THERAPY; CANCER REGISTRY; DISEASE SURVEILLANCE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MEDICAL AUDIT; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; UNITED KINGDOM;

ENGLAND; HUMANS; MALE; MEDICAL AUDIT; PROSTATIC NEOPLASMS; WALES;

EID: 84886065749     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12365     Document Type: Review

References (6)

1. Wong LM, Johnston R, Sharma N, Shah NC, Warren AY, Neal DE,. General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations. BJU Int 2012; 110: 24-27
2. Dall'Era MA, Albertsen PC, Bangma C, et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 2012; 62: 976-983
3. Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360: 103-106
4. Bolla M, van Poppel H, Tombal B, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 2012; 380: 2018-2027
5. Lyratzopoulos G, Barbiere JM, Greenberg DC, Wright KA, Neal DE,. Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey. BMJ 2010; 340: c1928
6. Lyratzopoulos G, Abel GA, Brown CH, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol 2013; 24: 843-850